ORYZF Earnings
Oryzon Genomics S.A.
1W: -6.3%
1M: -5.2%
3M: -15.1%
YTD: -7.7%
1Y: -8.3%
$3.10
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Last Earnings
2026-02-27
EPS
€-0.02 (US$-0.03)
▲ Beat +41.8%
Revenue
$2M
Est (actual pending)
Next Earnings
2026-11-06
EPS Estimate
€-0.07 (US$-0.08)
Range: €-0.07 - €-0.07
Revenue Estimate
€7M ($8M)
1 analysts
1 USD = 0.89 EUR
Estimate vs Actual
Earnings Surprise History
11/17
EPS Beats
1/17
Revenue Beats
65%
EPS Beat Rate
6%
Rev Beat Rate
Wall Street Forward Estimates
Quarterly
Annual
Estimate Revisions
Recent Revisions
| Date | Period | Fiscal Date | EPS Old | EPS New | Change | Rev Old | Rev New |
|---|---|---|---|---|---|---|---|
| 2026-10-02 | annual | 2026-12-31 | €-0.10 | €-0.10 | — | €8,882,599 | €8,871,870 |
| 2026-10-02 | annual | 2030-12-31 | €2.21 | €2.22 | ▲ 0.01 | €340,671,282 | €340,259,789 |
| 2026-10-02 | quarter | 2027-09-30 | €-0.08 | €-0.08 | — | €5,818,667 | €5,818,667 |
| 2026-10-02 | quarter | 2026-09-30 | €-0.07 | €-0.07 | — | €8,021,881 | €8,021,881 |
| 2026-10-02 | annual | 2028-12-31 | €0.36 | €0.36 | — | €112,251,844 | €112,116,256 |
| 2026-10-02 | quarter | 2027-06-30 | €-0.07 | €-0.07 | — | €6,305,023 | €6,305,023 |
| 2026-10-02 | annual | 2029-12-31 | €1.58 | €1.58 | — | €245,380,579 | €245,084,186 |
| 2026-10-02 | annual | 2027-12-31 | €-0.01 | €-0.01 | — | €27,091,928 | €27,059,204 |
| 2026-10-02 | quarter | 2027-03-30 | €-0.07 | €-0.07 | — | €6,832,031 | €6,832,031 |
| 2026-10-02 | quarter | 2027-12-30 | €-0.08 | €-0.08 | — | €5,369,827 | €5,369,827 |
| 2026-10-02 | quarter | 2026-12-30 | €-0.07 | €-0.07 | — | €7,403,090 | €7,403,090 |
| 2026-10-01 | quarter | 2027-09-30 | €-0.08 | €-0.08 | — | €5,818,667 | €5,818,667 |
| 2026-10-01 | quarter | 2026-12-30 | €-0.07 | €-0.07 | — | €7,403,090 | €7,403,090 |
| 2026-10-01 | quarter | 2026-09-30 | €-0.07 | €-0.07 | — | €8,021,881 | €8,021,881 |
| 2026-10-01 | quarter | 2027-12-30 | €-0.08 | €-0.08 | — | €5,369,827 | €5,369,827 |
Earnings Call Transcripts
No transcripts available.